These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2458848)

  • 1. [Screening for alpha-1-fetoprotein in maternal serum. Clinical and organizational aspects in the Central Bohemia Region].
    Stejskal D; Malbohan I
    Cesk Gynekol; 1988 Aug; 53(7):538-43. PubMed ID: 2458848
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alpha-fetoprotein and trisomy 21].
    Guibaud S; Boisson C; Simplot A; Thoulon JM; Favier JP; Guibaud P; Robert JM
    J Genet Hum; 1988 Aug; 36(4):347-51. PubMed ID: 2464665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current difficulties in use of maternal serum alpha-fetoprotein levels in counseling mid-trimester older pregnant women regarding risk of a Down syndrome fetus.
    Hook EB
    Am J Med Genet; 1988 Sep; 31(1):247-50. PubMed ID: 2464934
    [No Abstract]   [Full Text] [Related]  

  • 4. Maternal serum alpha-fetoprotein screening for Down syndrome: economic considerations.
    Swint JM; Greenberg F
    Am J Med Genet; 1988 Sep; 31(1):231-45. PubMed ID: 2464933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cautions about maternal serum alpha-fetoprotein screening.
    Milunsky A; Haddow JE
    N Engl J Med; 1985 Sep; 313(11):694. PubMed ID: 2410789
    [No Abstract]   [Full Text] [Related]  

  • 6. Maternal serum screening for fetal Down syndrome in IVF pregnancies.
    Ribbert LS; Kornman LH; De Wolf BT; Simons AH; Jansen CA; Beekhuis JR; Mantingh A
    Prenat Diagn; 1996 Jan; 16(1):35-8. PubMed ID: 8821850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome.
    Spencer K
    Ann Clin Biochem; 2001 Jul; 38(Pt 4):413-4. PubMed ID: 11471889
    [No Abstract]   [Full Text] [Related]  

  • 8. Second-trimester maternal serum screening for Down syndrome in Mainland China.
    Liao C; Huang Y; Li D; Song S; Yi C; Zhou J
    Prenat Diagn; 2006 Dec; 26(13):1271-2. PubMed ID: 17139699
    [No Abstract]   [Full Text] [Related]  

  • 9. 46,XY,i(21q) identified by maternal serum screening.
    Meyers CM; Ghori S; Roberson AE; Blitzer MG; Cohen MM
    Md Med J; 1997 Feb; 46(2):88-9. PubMed ID: 9029908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Does systemic determination of maternal serum alpha-1-fetoprotein have any value?].
    Muller F; Pantin G; Normand N; Bucheton D; Der Sarkissian H; Boué J; Giraudet P; Henrion R; Boué A
    Arch Fr Pediatr; 1990; 47(6):473-4. PubMed ID: 1698351
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
    Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doubts using family history, age, alpha-fetoprotein and total human chorionic gonadotrophin in screening for Down's syndrome.
    Ogueh O
    Br J Obstet Gynaecol; 1995 Apr; 102(4):349-50. PubMed ID: 7542022
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical uses of maternal serum markers in the prenatal diagnosis].
    Li G; Huang X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Apr; 33(4):252-4. PubMed ID: 10682475
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical significance of low serum alpha fetoprotein].
    Hod M; Friedman S; Pick I; Ovadia J
    Harefuah; 1989 Nov; 117(10):305-10. PubMed ID: 2482239
    [No Abstract]   [Full Text] [Related]  

  • 16. [A study on the screening of prenatal trisomy 21 using the fucosylated alpha-fetoprotein ratio measured by a liquid-phase binding assay].
    Minobe S
    Hokkaido Igaku Zasshi; 2002 Nov; 77(6):527-32. PubMed ID: 12491624
    [No Abstract]   [Full Text] [Related]  

  • 17. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal trisomy 21 screening using the Lens culinaris agglutinin-reactive alpha-fetoprotein ratio.
    Yamamoto R; Minobe S; Ebina Y; Watari H; Kudo M; Henmi F; Satomura S; Fujimoto S; Minakami H; Sakuragi N
    Congenit Anom (Kyoto); 2004 Jun; 44(2):87-92. PubMed ID: 15198721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of maternal serum screening programs for Down syndrome in southeast Michigan, 1988-2003.
    Van Dyke DL; Ebrahim SA; Al Saadi AA; Powell SA; Zenger-Hain JL; Micale MA; Wiktor AE; Zou YS
    Prenat Diagn; 2007 Jun; 27(6):583-4. PubMed ID: 17546696
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for maternal serum alpha-fetoprotein: what about the low side?
    Lippman A; Evans JA
    CMAJ; 1987 Apr; 136(8):801-4. PubMed ID: 2436735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.